Alexander J A Deutsch Selected Research

FL-70

4/2014

NR4A1-mediated apoptosis suppresses lymphomagenesis and is associated with a favorable cancer-specific survival in patients with aggressive B-cell lymphomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alexander J A Deutsch Research Topics

Disease

4	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2018 - 02/2013
4	Neoplasms (Cancer) 05/2015 - 11/2012
2	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 02/2013 - 01/2011
1	Hepatocellular Carcinoma (Hepatoma) 01/2022
1	Lymphoma (Lymphomas) 01/2018
1	Polyploidy 05/2015
1	Chordoma 05/2015
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 04/2014
1	B-Cell Leukemia (Leukemia, B Cell) 04/2014
1	Gastritis 02/2013
1	Melanoma (Melanoma, Malignant) 05/2012
1	Hashimoto Disease (Thyroiditis, Hashimoto) 01/2011

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 01/2018 - 05/2015
1	Sorafenib (BAY 43-9006)FDA Link 01/2022
1	Caspase 3 (Caspase-3)IBA 01/2018
1	Peptide Initiation Factors (Initiation Factor)IBA 01/2018
1	SurvivinIBA 05/2015
1	sepantroniumIBA 05/2015
1	FL-70IBA 04/2014
1	ChemokinesIBA 02/2013
1	LigandsIBA 02/2013
1	Chemokine ReceptorsIBA 02/2013
1	Messenger RNA (mRNA)IBA 02/2013
1	shikoninIBA 05/2012
1	acetylshikoninIBA 05/2012
1	isovalerylshikoninIBA 05/2012
1	naphthaIBA 05/2012
1	NaphthoquinonesIBA 05/2012
1	DNA (Deoxyribonucleic Acid)IBA 01/2011

Therapy/Procedure

2	Therapeutics 01/2015 - 11/2012